Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics.
OBJECTIVE
In the late 1980s, the cloning of several nuclear receptors led to the intense search and isolation of new members of this superfamily. Despite their identification, many of these receptors were dubbed 'orphan' receptors, as their physiological ligands remained unknown. Recent reports have presented evidence for one family of orphan receptors, the retinoic acid receptor-related orphan receptors (RORs), in several pathologies, including osteoporosis, several autoimmune diseases, asthma, cancer, diabetes and obesity. The present review summarizes the studies identifying ligands for the RORs and evaluates their role as targets for potential therapeutics.


RESULTS
Significant progress was made in the initial identification of ligands for the RORs when X-ray crystallographic studies identified several molecules within the ligand-binding pockets of RORalpha and RORbeta. Recently, we identified endogenous and synthetic ligands for RORalpha and RORgamma, thereby solidifying their function as ligand-dependent transcription factors.


CONCLUSIONS
Recent studies have established roles for the RORs in physiological development and the advent of disease. Identification of ligands for the RORs, both endogenous and synthetic, has established these receptors as attractive new therapeutic targets for the treatment of ROR-related diseases.
Solt
Laura A
LA
The Scripps Research Institute, Jupiter, Florida 33458, USA.
Griffin
Patrick R
PR
Burris
Thomas P
TP
D000818:Animals; D055808:Drug Discovery; D006801:Humans; D008024:Ligands; D057094:Nuclear Receptor Subfamily 1, Group F, Member 1 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism
D008024:Ligands; D057094:Nuclear Receptor Subfamily 1, Group F, Member 1; D014157:Transcription Factors
Cancer Res. 2002 Feb 1;62(3):901-9
11830550
Circulation. 1998 Dec 15;98(24):2738-43
9851961
Nat Immunol. 2008 Jun;9(6):641-9
18454151
Genomics. 1995 Aug 10;28(3):596-8
7490103
J Immunol. 2008 Apr 1;180(7):4785-92
18354202
Eur J Neurosci. 1997 Dec;9(12):2687-701
9517474
EMBO J. 1998 Jul 15;17(14):3867-77
9670004
Adv Dev Biol. 2006;16:313-355
18418469
Cell Metab. 2009 Dec;10(6):481-90
19945405
Immunity. 1998 Dec;9(6):797-806
9881970
Biochem Biophys Res Commun. 1993 Aug 16;194(3):1371-9
7916608
Mol Cell Biol. 2010 Feb;30(3):793-805
19933845
Nature. 1996 Feb 22;379(6567):736-9
8602221
Mol Endocrinol. 1994 Jun;8(6):757-70
7935491
Genes Dev. 1994 Mar 1;8(5):538-53
7926749
Cell. 2002 Jul 26;110(2):251-60
12150932
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1976-83
7811290
Nat Immunol. 2008 Nov;9(11):1297-306
18849990
Structure. 2002 Dec;10(12):1697-707
12467577
Cell Death Differ. 2002 Nov;9(11):1167-71
12404115
J Biol Chem. 1996 Jul 26;271(30):17852-60
8663356
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10132-7
10963675
Nat Struct Biol. 2003 Oct;10(10):820-5
12958591
Nat Rev Drug Discov. 2002 Apr;1(4):259-66
12120277
Science. 2007 Dec 14;318(5857):1786-9
18006707
FEBS Lett. 2002 Jan 30;511(1-3):36-40
11821045
J Lipid Res. 1997 Sep;38(9):1730-45
9323583
J Neurochem. 1992 Jan;58(1):192-9
1727430
Neuron. 2003 Dec 18;40(6):1119-31
14687547
Biochem Biophys Res Commun. 2004 Mar 19;315(4):919-27
14985100
Nature. 2008 Jul 17;454(7202):350-2
18469800
Science. 2008 Nov 28;322(5906):1395-9
19039140
Oncogene. 2006 May 11;25(20):2901-8
16462772
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9197-202
10900268
Science. 2000 Jun 30;288(5475):2369-73
10875923
J Biol Chem. 2008 Jun 27;283(26):18411-21
18441015
Nat Struct Mol Biol. 2007 Dec;14(12):1207-13
18037887
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15505-10
18832156
EMBO J. 2001 Nov 1;20(21):5822-31
11689423
Semin Immunol. 2007 Dec;19(6):409-17
18053739
Cell Metab. 2006 Jul;4(1):37-48
16814731
Mol Endocrinol. 2008 Jul;22(7):1509-20
18218725
J Pathol. 2010 Mar;220(4):499-508
20020510
Anal Biochem. 2003 Dec 1;323(1):139-49
14622968
Mol Pharmacol. 2008 Mar;73(3):891-9
18055760
Neuron. 2004 Aug 19;43(4):527-37
15312651
Cancer Lett. 2006 Jan 28;232(1):48-57
16221525
Gastroenterology. 2008 Feb;134(2):556-67
18242221
Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):156-9
7816808
Mol Endocrinol. 1997 Oct;11(11):1737-46
9328355
J Exp Med. 2008 May 12;205(5):1063-75
18411338
J Biol Chem. 2010 Feb 12;285(7):5013-25
19965867
Physiol Genomics. 2007 Oct 22;31(2):281-94
17666523
Nucleic Acids Res. 1999 Jan 15;27(2):411-20
9862959
PLoS One. 2009;4(5):e5609
19440305
Nat Struct Mol Biol. 2005 May;12(5):441-8
15821743
Nature. 2007 May 24;447(7143):477-81
17476214
J Leukoc Biol. 2009 Aug;86(2):401-9
19406833
Dev Biol. 1992 Apr;150(2):306-18
1372571
FEBS Lett. 2007 May 1;581(9):1721-6
17418145
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3960-5
9520475
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6167-71
1631105
Mol Endocrinol. 1999 Sep;13(9):1550-7
10478845
Atherosclerosis. 1999 Jan;142(1):1-28
9920502
Steroids. 2007 Mar;72(3):231-46
17284330
J Biol Chem. 2004 Apr 2;279(14):14033-8
14722075
Genes Dev. 2009 Dec 1;23(23):2711-6
19952106
Nucleic Acids Res. 1995 Feb 11;23(3):327-33
7885826
Mol Pharmacol. 2010 Feb;77(2):228-36
19887649
Nucl Recept Signal. 2009;7:e003
19381306
Mol Genet Metab. 2004 Sep-Oct;83(1-2):184-7
15464433
Free Radic Biol Med. 2007 Mar 1;42(5):698-705
17291993
Cell. 2006 Sep 22;126(6):1121-33
16990136